-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DB59gHOfbSZFRURAtMKU2EzkV/ArjgDvlANmeY0VXgg02VilnKHfEd0ENoYCdcNi EjAFDIR3s+1BDg4TYucTdQ== 0001209191-08-037754.txt : 20080618 0001209191-08-037754.hdr.sgml : 20080618 20080618112225 ACCESSION NUMBER: 0001209191-08-037754 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070301 FILED AS OF DATE: 20080618 DATE AS OF CHANGE: 20080618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PENWEST PHARMACEUTICALS CO CENTRAL INDEX KEY: 0001047188 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911513032 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 39 OLD RIDGEBURY ROAD STREET 2: SUITE 11 CITY: DANBURY STATE: CT ZIP: 06810-5120 BUSINESS PHONE: 877-736-9378 MAIL ADDRESS: STREET 1: 39 OLD RIDGEBURY ROAD STREET 2: SUITE 11 CITY: DANBURY STATE: CT ZIP: 06810-5120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCIASCIA THOMAS CENTRAL INDEX KEY: 0001229946 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23467 FILM NUMBER: 08904927 BUSINESS ADDRESS: STREET 1: C/O PENNWEST PHARMACEUTICALS CO. STREET 2: 39 OLD RIDGEBURY ROAD, STE. 11 CITY: DANBURY STATE: CT ZIP: 06810-5120 BUSINESS PHONE: 203 796-3701 MAIL ADDRESS: STREET 1: 39 OLD RIDGEBURY RD. SUITE 11 CITY: DANBURY STATE: CT ZIP: 06810 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0202 4/A 2007-03-01 2007-03-02 0 0001047188 PENWEST PHARMACEUTICALS CO PPCO 0001229946 SCIASCIA THOMAS 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120 0 1 0 0 Chief Medical Officer Stock Option (Right-to-Buy) 13.02 2007-03-02 4 A 0 45000 13.02 A 2011-03-01 2017-03-01 Common Stock 45000 45000 D This amendment is filed for the sole purpose of attaching a power of attorney. The options vest in four equal annual installments with the first installment vesting on 03/01/2008. /s/Ling Zeng, Attorney-in-Fact for Thomas Sciascia 2008-06-17 EX-24.4A_246301 2 poa.txt POA DOCUMENT LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS Know all by these present, that the undersigned hereby makes, constitutes and appoints Jennifer L. Good, Benjamin L. Palleiko, Ling Zeng, each signing singly and acting individually, as the undersigned's true and lawful attorney in fact with full power and authority as hereinafter described to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a director of Penwest Pharmaceuticals Co. (the "Company"), Forms 3, 4, and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder (the "Exchange Act"); (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to prepare, complete and execute any such Form 3, 4, or 5, prepare, complete and execute any amendment or amendments thereto, and timely deliver and file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; (3) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information regarding transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to such attorney in fact and approves and ratifies any such release of information; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney in fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney in fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney in fact may approve in such attorney in fact's discretion. The undersigned hereby grants to such attorney in fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney in fact, or such attorney in fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney in fact, in serving in such capacity at the request of the undersigned, are not assuming nor relieving, nor is the Company assuming nor relieving, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. The undersigned acknowledges that neither the Company nor the foregoing attorney in fact assume (i) any liability for the undersigned's responsibility to comply with the requirement of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney in fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1st day of February, 2007. /s/Thomas Sciascia -----END PRIVACY-ENHANCED MESSAGE-----